Antiretroviral agents

Roger Finch, Peter Davey, Mark Wilcox and William Irving

in Antimicrobial Chemotherapy

Sixth edition

Published on behalf of Oxford University Press

Published in print January 2012 | ISBN: 9780199697656
Published online November 2013 | e-ISBN: 9780191770821 | DOI:
Antiretroviral agents

More Like This

Show all results sharing these subjects:

  • Pharmacology
  • Infectious Diseases
  • Medical Microbiology and Virology


Show Summary Details


Chapter 5 discusses antiretroviral drugs, which are commonly formulated as combination products in the hope of suppressingthe development of resistance, to simplify the often complex dosage regimens that are required for effective therapy and, in some cases, to exploit possible synergistic interactions. It also discusses how the frequent occurrence of toxic interactions between various antiretroviral compounds demands careful selection of such drug permutations. It covers reverse transcriptase inhibitors (RTIs), non-nucleoside analogue reverse transcriptase inhibitors (NNRTIs), protease inhibitors, fusion inhibitors, CCR5 binding inhibitors, integrase inhibitors, and resistance to anti-HIV drugs.

Chapter.  2709 words.  Illustrated.

Subjects: Pharmacology ; Infectious Diseases ; Medical Microbiology and Virology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.